Main industries: Body care, health products, hair care
TOP 3 markets:

1. India: approx. 70%
2. Bangladesh: approx. 10%
3. Nepal: approx. 5%

Emami Limited generates the majority of its revenue from the body care industry, followed by health and hair care products. India remains the dominant market for Emami, attributed to its strong brand presence and extensive distribution network in the domestic market. Bangladesh and Nepal are also important markets where Emami has established a foothold through strategic expansion and local adjustments to its product range. The remaining revenue is distributed across other international markets and product categories.

Production sites of Emami Limited:

1. India:
   • Kolkata, West Bengal
   • Assam
   • Gujarat
   • Maharashtra
   • Tamil Nadu

Emami Limited is a leading Indian company in the consumer goods sector, particularly known for its products in the areas of personal care and health. The company operates multiple production facilities in India to meet demand both in the domestic market and internationally. The strategic distribution of production sites enables Emami to produce efficiently and optimize logistics costs.

Revenue Growth: Estimated 8-10% annually (2026)

Market Expansion: Focus on international markets, especially Asia and Africa

Product Innovation: Introduction of new health and wellness products

Emami Limited is pursuing a growth strategy based on expanding into international markets. The company aims to strengthen its presence in Asia and Africa to benefit from the growing consumer markets in these regions.

Another focus is on product innovation. Emami plans to expand its portfolio in the health and wellness products sector to meet the increasing consumer trends towards natural and Ayurvedic products.

Additionally, the company is investing in digital marketing strategies and e-commerce platforms to increase its reach and enhance brand awareness. These measures are intended to help maintain stable revenue growth in the coming years.

Main raw materials: Palm oil, paraffin, herbal extracts

Countries of origin:

• Palm oil: Malaysia, Indonesia
• Paraffin: USA, Saudi Arabia
• Herbal extracts: Various Asian countries, especially China and India

Emami Limited imports a variety of raw materials essential for the production of their cosmetic and body care products. Palm oil and paraffin are two of the most important raw materials, mainly sourced from Malaysia, Indonesia, the USA, and Saudi Arabia. These materials are crucial for the production of Emami's well-known products such as creams and oils.

In addition, the company sources special herbal extracts from various Asian countries to ensure the natural ingredients of their products. These imports are important to guarantee the quality and effectiveness of the products that Emami brings to the market.

Market Share: 7.5% in the Indian FMCG sector (2025)
EBITDA Margin: 28.3% (2025)
R&D Investments: 2.1% of revenue (2025)

Emami Limited has established itself as a significant player in the Indian FMCG sector, especially in the areas of skincare and health products. The market share of 7.5% demonstrates a solid presence, particularly in niche markets and in ayurvedic products, which are highly demanded in India.

The high EBITDA margin of 28.3% indicates an efficient cost structure and strong pricing power, suggesting a competitive advantage. Emami continuously invests in research and development to introduce innovative products to the market, supported by R&D investments of 2.1% of revenue.

In summary, Emami Limited possesses a significant competitive advantage in the Indian FMCG market through its strong brand presence, innovative product range, and efficient cost structure. The ongoing investments in research and development further strengthen this advantage.

Institutional Investor Share: 30% (estimated, 2026)
Insider Trades: No significant transactions reported (2026)

The institutional investor share in Emami Limited is estimated to be around 30%. This estimate is based on historical data and typical market trends for companies of this size and industry.

In 2026, no significant insider buys or sells were reported. This may indicate that the management and other insiders have confidence in the current company strategy and valuation. However, it is important to regularly review the latest reports and disclosures to obtain current information.

Market share of Emami Limited: 5.2% (2026, estimated)

Top competitors and their market share:

1. Hindustan Unilever Limited: 25.4%
2. ITC Limited: 18.7%
3. Dabur India Limited: 12.3%
4. Godrej Consumer Products Limited: 9.8%
5. Marico Limited: 8.1%
6. Emami Limited: 5.2%
7. Colgate-Palmolive India: 4.9%
8. Procter & Gamble Hygiene and Health Care: 3.6%
9. Patanjali Ayurved: 3.2%
10. Jyothy Labs: 2.8%

Moat of Emami Limited:

Emami Limited has a moderate moat, mainly based on its strong brand presence and diversified product portfolio in the body care and health sectors. The company has made a name for itself through innovative products and a strong distribution strategy, especially in the ayurvedic and natural products segments.

However, compared to its competitors, Emami has a less pronounced moat. Hindustan Unilever and ITC have a wider range of products and a stronger international presence, giving them a significant competitive advantage. Dabur and Patanjali also benefit from strong brand loyalty in the natural and ayurvedic products segment, strengthening their position.

Overall, Emami Limited does have a certain competitive advantage, but it is less pronounced compared to larger competitors. To expand its moat, Emami could invest in international expansion and further development of its product lines.

Revenue Growth: 8.5% (2025) Profit Growth: 10.2% (2025) Market Share in Core Segments: 12% (2025)

Emami Limited recorded a revenue growth of 8.5% in 2025, attributed to successful expansion into new markets and the introduction of new products. The profit growth of 10.2% indicates that the company was able to increase its efficiency and benefit from an improved cost structure.

The company holds a market share of 12% in its core segments, highlighting its strong position in the industry. Emami has also invested in research and development to expand its product range and differentiate itself from the competition.

Overall, Emami Limited demonstrates solid fundamental data and positive growth dynamics, making it a potentially attractive investment. However, investors should also consider external factors such as market trends and economic conditions before making a final decision.

Dividend Yield: 2.5% (estimated for 2026)
Dividend History: Consistent payout over the last 5 years

Emami Limited has regularly distributed dividends to its shareholders in recent years. The dividend yield is estimated to be around 2.5% for 2026, based on historical payouts and current market performance.

The company has demonstrated a reliable dividend policy, with no interruptions in payouts over the past five years. This indicates that Emami Limited is committed to consistently returning capital to its shareholders, reflecting solid financial health and stable cash flows.